Malinoski FJ[Author] - Search Results

Year	Number of Results
1978	1
1990	2
1992	2
1998	3
2000	1
2001	2
2004	2
2006	2
2007	1
2008	2
2009	1
2012	2
2013	1
2014	1
2020	1
2022	1
2024	0

1

Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?

Fletcher MA, Laufer DS, McIntosh ED, Cimino C, Malinoski FJ. Fletcher MA, et al. Among authors: malinoski fj. Int J Clin Pract. 2006 Apr;60(4):450-6. doi: 10.1111/j.1368-5031.2006.00858.x. Int J Clin Pract. 2006. PMID: 16620359 Free PMC article. Review.

2

Pneumonia vaccine.

Malinoski FJ, Laufer DS. Malinoski FJ, et al. J Fam Pract. 2001 Oct;50(10):902. J Fam Pract. 2001. PMID: 11674899 No abstract available.

3

Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk.

McIntosh ED, Malinoski FJ, Randolph VB. McIntosh ED, et al. Among authors: malinoski fj. Expert Rev Vaccines. 2004 Aug;3(4):353-7. doi: 10.1586/14760584.3.4.353. Expert Rev Vaccines. 2004. PMID: 15270633 Review.

4

Post-marketing effectiveness of Prevnar [pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)] and implications for adult immunization.

Parijs BA, Malinoski FJ. Parijs BA, et al. Among authors: malinoski fj. Mech Ageing Dev. 2004 Feb;125(2):147-8. doi: 10.1016/j.mad.2003.12.001. Mech Ageing Dev. 2004. PMID: 15037021 Review.

5

Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC.

Harutyunyan S, Neuhauser I, Mayer A, Aichinger M, Szijártó V, Nagy G, Nagy E, Girardi P, Malinoski FJ, Henics T. Harutyunyan S, et al. Among authors: malinoski fj. Vaccines (Basel). 2020 Nov 16;8(4):689. doi: 10.3390/vaccines8040689. Vaccines (Basel). 2020. PMID: 33207794 Free PMC article.

6

Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial.

Girardi P, Harutyunyan S, Neuhauser I, Glaninger K, Korda O, Nagy G, Nagy E, Szijártó V, Pall D, Szarka K, Kardos G, Henics T, Malinoski FJ. Girardi P, et al. Among authors: malinoski fj. Vaccines (Basel). 2022 Feb 21;10(2):340. doi: 10.3390/vaccines10020340. Vaccines (Basel). 2022. PMID: 35214798 Free PMC article.

7

Development of a nanoparticle-based influenza vaccine using the PRINT technology.

Galloway AL, Murphy A, DeSimone JM, Di J, Herrmann JP, Hunter ME, Kindig JP, Malinoski FJ, Rumley MA, Stoltz DM, Templeman TS, Hubby B. Galloway AL, et al. Among authors: malinoski fj. Nanomedicine. 2013 May;9(4):523-31. doi: 10.1016/j.nano.2012.11.001. Epub 2012 Nov 22. Nanomedicine. 2013. PMID: 23178283

8

US Military contributions to the global response to pandemic chikungunya.

Hoke CH Jr, Pace-Templeton J, Pittman P, Malinoski FJ, Gibbs P, Ulderich T, Mathers M, Fogtman B, Glass P, Vaughn DW. Hoke CH Jr, et al. Among authors: malinoski fj. Vaccine. 2012 Oct 19;30(47):6713-20. doi: 10.1016/j.vaccine.2012.08.025. Epub 2012 Aug 29. Vaccine. 2012. PMID: 22940380

9

Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab.

Mahadevia PJ, Malinoski FJ. Mahadevia PJ, et al. Among authors: malinoski fj. Arch Pediatr Adolesc Med. 2007 May;161(5):519-20; author reply 520. doi: 10.1001/archpedi.161.5.519. Arch Pediatr Adolesc Med. 2007. PMID: 17485634 No abstract available.

10

The nanomedicines alliance: an industry perspective on nanomedicines.

Malinoski FJ. Malinoski FJ. Nanomedicine. 2014 Nov;10(8):1819-20. doi: 10.1016/j.nano.2014.07.003. Epub 2014 Jul 16. Nanomedicine. 2014. PMID: 25038497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year